Cargando…
Quantitative assessment of tumor-infiltrating lymphocytes in mismatch repair proficient colon cancer
Tumor infiltrating lymphocytes (TIL), which represent host adaptive response to the tumor, were first identified at scanning magnification to select areas with the highest counts on hematoxylin and eosin slides, quantitated per high-power field (HPF), and analyzed for association with recurrence-fre...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7671050/ https://www.ncbi.nlm.nih.gov/pubmed/33235819 http://dx.doi.org/10.1080/2162402X.2020.1841948 |
_version_ | 1783610854019694592 |
---|---|
author | Jimenez-Rodriguez, Rosa M. Patil, Sujata Keshinro, Ajaratu Shia, Jinru Vakiani, Efsevia Stadler, Zsofia Segal, Neil H. Yaeger, Rona Konishi, Tsuyoshi Shimada, Yoshifumi Widmar, Maria Wei, Iris Pappou, Emmanouil Smith, J. Joshua Nash, Garrett Paty, Philip Garcia-Aguilar, Julio Weiser, Martin R. |
author_facet | Jimenez-Rodriguez, Rosa M. Patil, Sujata Keshinro, Ajaratu Shia, Jinru Vakiani, Efsevia Stadler, Zsofia Segal, Neil H. Yaeger, Rona Konishi, Tsuyoshi Shimada, Yoshifumi Widmar, Maria Wei, Iris Pappou, Emmanouil Smith, J. Joshua Nash, Garrett Paty, Philip Garcia-Aguilar, Julio Weiser, Martin R. |
author_sort | Jimenez-Rodriguez, Rosa M. |
collection | PubMed |
description | Tumor infiltrating lymphocytes (TIL), which represent host adaptive response to the tumor, were first identified at scanning magnification to select areas with the highest counts on hematoxylin and eosin slides, quantitated per high-power field (HPF), and analyzed for association with recurrence-free survival (RFS) in 848 patients. Highest TIL in a single HPF was analyzed as a continuous and categorical variable, and optimal cutoff analysis was performed to predict RFS. Highest TIL count in a single HPF ranged from 0 to 45, and the optimal cutoff for TIL high vs TIL low was determined to be ≥ 3 vs < 3 with a concordance probability estimate of 0.74. In the entire cohort, 5-year RFS was 90.2% (95% CI = 83.7–94.2) in TIL high compared to 78.9% (95% CI = 74.1–82.9) in TIL low (log rank P < .0001). TIL remained significant in the mismatch repair-proficient (pMMR) cohort where 5-year RFS was 94.6% (95% CI = 88.3–97.5) in TIL high compared to 77.9% (95% CI = 69.2–84.4) in TIL low (P = .008). On multivariable analysis, TIL and AJCC Stage were independently associated with RFS in the pMMR cohort. Qualitatively in the pMMR cohort, RFS in Stage II TIL high patients was similar to that in Stage I patients and RFS in Stage III TIL high was similar to that in Stage II TIL low patients. Assessment of TIL in a single HPF using standard H&E slides provides important prognostic information independent of MMR status and AJCC stage. |
format | Online Article Text |
id | pubmed-7671050 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-76710502020-11-23 Quantitative assessment of tumor-infiltrating lymphocytes in mismatch repair proficient colon cancer Jimenez-Rodriguez, Rosa M. Patil, Sujata Keshinro, Ajaratu Shia, Jinru Vakiani, Efsevia Stadler, Zsofia Segal, Neil H. Yaeger, Rona Konishi, Tsuyoshi Shimada, Yoshifumi Widmar, Maria Wei, Iris Pappou, Emmanouil Smith, J. Joshua Nash, Garrett Paty, Philip Garcia-Aguilar, Julio Weiser, Martin R. Oncoimmunology Original Research Tumor infiltrating lymphocytes (TIL), which represent host adaptive response to the tumor, were first identified at scanning magnification to select areas with the highest counts on hematoxylin and eosin slides, quantitated per high-power field (HPF), and analyzed for association with recurrence-free survival (RFS) in 848 patients. Highest TIL in a single HPF was analyzed as a continuous and categorical variable, and optimal cutoff analysis was performed to predict RFS. Highest TIL count in a single HPF ranged from 0 to 45, and the optimal cutoff for TIL high vs TIL low was determined to be ≥ 3 vs < 3 with a concordance probability estimate of 0.74. In the entire cohort, 5-year RFS was 90.2% (95% CI = 83.7–94.2) in TIL high compared to 78.9% (95% CI = 74.1–82.9) in TIL low (log rank P < .0001). TIL remained significant in the mismatch repair-proficient (pMMR) cohort where 5-year RFS was 94.6% (95% CI = 88.3–97.5) in TIL high compared to 77.9% (95% CI = 69.2–84.4) in TIL low (P = .008). On multivariable analysis, TIL and AJCC Stage were independently associated with RFS in the pMMR cohort. Qualitatively in the pMMR cohort, RFS in Stage II TIL high patients was similar to that in Stage I patients and RFS in Stage III TIL high was similar to that in Stage II TIL low patients. Assessment of TIL in a single HPF using standard H&E slides provides important prognostic information independent of MMR status and AJCC stage. Taylor & Francis 2020-11-11 /pmc/articles/PMC7671050/ /pubmed/33235819 http://dx.doi.org/10.1080/2162402X.2020.1841948 Text en © 2020 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Research Jimenez-Rodriguez, Rosa M. Patil, Sujata Keshinro, Ajaratu Shia, Jinru Vakiani, Efsevia Stadler, Zsofia Segal, Neil H. Yaeger, Rona Konishi, Tsuyoshi Shimada, Yoshifumi Widmar, Maria Wei, Iris Pappou, Emmanouil Smith, J. Joshua Nash, Garrett Paty, Philip Garcia-Aguilar, Julio Weiser, Martin R. Quantitative assessment of tumor-infiltrating lymphocytes in mismatch repair proficient colon cancer |
title | Quantitative assessment of tumor-infiltrating lymphocytes in mismatch repair proficient colon cancer |
title_full | Quantitative assessment of tumor-infiltrating lymphocytes in mismatch repair proficient colon cancer |
title_fullStr | Quantitative assessment of tumor-infiltrating lymphocytes in mismatch repair proficient colon cancer |
title_full_unstemmed | Quantitative assessment of tumor-infiltrating lymphocytes in mismatch repair proficient colon cancer |
title_short | Quantitative assessment of tumor-infiltrating lymphocytes in mismatch repair proficient colon cancer |
title_sort | quantitative assessment of tumor-infiltrating lymphocytes in mismatch repair proficient colon cancer |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7671050/ https://www.ncbi.nlm.nih.gov/pubmed/33235819 http://dx.doi.org/10.1080/2162402X.2020.1841948 |
work_keys_str_mv | AT jimenezrodriguezrosam quantitativeassessmentoftumorinfiltratinglymphocytesinmismatchrepairproficientcoloncancer AT patilsujata quantitativeassessmentoftumorinfiltratinglymphocytesinmismatchrepairproficientcoloncancer AT keshinroajaratu quantitativeassessmentoftumorinfiltratinglymphocytesinmismatchrepairproficientcoloncancer AT shiajinru quantitativeassessmentoftumorinfiltratinglymphocytesinmismatchrepairproficientcoloncancer AT vakianiefsevia quantitativeassessmentoftumorinfiltratinglymphocytesinmismatchrepairproficientcoloncancer AT stadlerzsofia quantitativeassessmentoftumorinfiltratinglymphocytesinmismatchrepairproficientcoloncancer AT segalneilh quantitativeassessmentoftumorinfiltratinglymphocytesinmismatchrepairproficientcoloncancer AT yaegerrona quantitativeassessmentoftumorinfiltratinglymphocytesinmismatchrepairproficientcoloncancer AT konishitsuyoshi quantitativeassessmentoftumorinfiltratinglymphocytesinmismatchrepairproficientcoloncancer AT shimadayoshifumi quantitativeassessmentoftumorinfiltratinglymphocytesinmismatchrepairproficientcoloncancer AT widmarmaria quantitativeassessmentoftumorinfiltratinglymphocytesinmismatchrepairproficientcoloncancer AT weiiris quantitativeassessmentoftumorinfiltratinglymphocytesinmismatchrepairproficientcoloncancer AT pappouemmanouil quantitativeassessmentoftumorinfiltratinglymphocytesinmismatchrepairproficientcoloncancer AT smithjjoshua quantitativeassessmentoftumorinfiltratinglymphocytesinmismatchrepairproficientcoloncancer AT nashgarrett quantitativeassessmentoftumorinfiltratinglymphocytesinmismatchrepairproficientcoloncancer AT patyphilip quantitativeassessmentoftumorinfiltratinglymphocytesinmismatchrepairproficientcoloncancer AT garciaaguilarjulio quantitativeassessmentoftumorinfiltratinglymphocytesinmismatchrepairproficientcoloncancer AT weisermartinr quantitativeassessmentoftumorinfiltratinglymphocytesinmismatchrepairproficientcoloncancer |